<SEC-DOCUMENT>0001140361-15-045037.txt : 20151218
<SEC-HEADER>0001140361-15-045037.hdr.sgml : 20151218
<ACCEPTANCE-DATETIME>20151218102849
ACCESSION NUMBER:		0001140361-15-045037
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20151215
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20151218
DATE AS OF CHANGE:		20151218

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BALCHEM CORP
		CENTRAL INDEX KEY:			0000009326
		STANDARD INDUSTRIAL CLASSIFICATION:	CHEMICALS & ALLIED PRODUCTS [2800]
		IRS NUMBER:				132578432
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13648
		FILM NUMBER:		151295624

	BUSINESS ADDRESS:	
		STREET 1:		P O BOX 600
		CITY:			NEW HAMPTON
		STATE:			NY
		ZIP:			10958
		BUSINESS PHONE:		8453265632

	MAIL ADDRESS:	
		STREET 1:		P O BOX 600
		CITY:			NEW HAMPTON
		STATE:			NY
		ZIP:			10958
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>BALCHEM CORPORATION 8-K 12-15-2015
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Summit Financial Printing, LLC
    Document created using EDGARfilings PROfile 3.6.2.0
    Copyright 1995 - 2015 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<hr style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 4px solid; MARGIN-RIGHT: auto">
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 14pt">UNITED STATES</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><a name="_DV_M1"><!--Anchor--></a><font style="FONT-SIZE: 14pt">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><a name="_DV_M2"><!--Anchor--></a><font style="FONT-SIZE: 12pt">Washington, D.C. 20549</font></div>

<div><br>
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><a name="_DV_M3"><!--Anchor--></a><font style="FONT-SIZE: 18pt">FORM 8-K</font></div>

<div><br>
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><a name="_DV_M4"><!--Anchor--></a>Current Report</div>

<div><br>
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

<div><br>
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Date of report (date of earliest event reported):&#160; December 15, 2015</div>

<div><br>
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><a name="_DV_M11"><!--Anchor--></a><font style="FONT-SIZE: 24pt">Balchem Corporation</font></div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><a name="_DV_M12"><!--Anchor--></a>(Exact name of registrant as specified in its charter)</div>

<div><br>
</div>

<table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="6df765f7f1f547e7bd11da8378512450" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 32%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Maryland</div>
</td>
<td style="WIDTH: 2%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 32%; VERTICAL-ALIGN: middle">
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">1-13648</div>
</td>
<td style="WIDTH: 2%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 32%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">13-257-8432</div>
</td>
</tr>

<tr>
<td style="WIDTH: 32%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">(State or other jurisdiction of incorporation)</div>
</td>
<td style="WIDTH: 2%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 32%; VERTICAL-ALIGN: middle">
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">(Commission File Number)</div>
</td>
<td style="WIDTH: 2%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 32%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">(IRS Employer Identification No.)</div>
</td>
</tr>
</table>

<div><br>
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><a name="_DV_M13"><!--Anchor--></a>52 Sunrise Park Road, New Hampton, NY 10958</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><a name="_DV_M14"><!--Anchor--></a>(Address of principal executive offices) (Zip Code)</div>

<div style="TEXT-ALIGN: center"><a name="_DV_M15"><!--Anchor--></a><br>
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Registrant&#8217;s telephone number, including area code: (845) 326-5600</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="58e95b3d82034ff2b987e6d34ea5aa6e" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">&#9744;</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="879c5390f56343e6b7dde3b03e8f7cc7" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">&#9744;</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="d3e17fa8067e4fbfa1a6cf5b0acf9149" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">&#9744;</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="00e8f11446bf4c73a887bf7e398735b9" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; align: right">&#9744;</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr>
</table>
</div>

<div><br>
</div>

<div>
<hr style="BORDER-BOTTOM: black 4px solid; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff; HEIGHT: 10px; COLOR: #ffffff; MARGIN-LEFT: auto; BORDER-TOP: black 1px solid; MARGIN-RIGHT: auto">
</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: justify">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="14b7af233dc949f6957731b74f804aa2" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; align: right">ITEM 7.01</td>
<td style="TEXT-ALIGN: justify; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">REGULATION FD DISCLOSURE.</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify"><br>
</div>

<div style="TEXT-ALIGN: justify; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">On December 18, 2015, Balchem Corporation (the &#8220;Company&#8221;) issued a press release announcing a dividend declared by the Company's Board of Directors on December 15, 2015.&#160; A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</div>

<div style="TEXT-ALIGN: justify"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><a name="FIS_SECTION_9_FINANCIAL_STATEMENTS_AND_E"><!--Anchor--></a></font><br>
</div>

<div style="TEXT-ALIGN: left">
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="877910fb4a174749ac668e859283b674" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 54pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; align: right">Item 9.01</td>
<td style="TEXT-ALIGN: left; WIDTH: auto; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold">Financial Statements and Exhibits.</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">(c)&#160; Exhibits</div>

<div><br>
</div>

<div>
<div>
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman'; FONT-SIZE: 10pt" id="a537be38aba4497b801bc0dd43841540" class="DSPFListTable" cellspacing="0" cellpadding="0">
<tr style="VERTICAL-ALIGN: top">
<td style="WIDTH: 72pt; VERTICAL-ALIGN: top; align: right">
<div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Exhibit 99.1</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; align: left">
<div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Press Release of Balchem Corporation, dated December 18, 2015.</div>
</td>
</tr>
</table>
</div>

<div>&#160;</div>
</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">SIGNATURE</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div><br>
</div>

<table style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; BORDER-TOP: medium none; BORDER-RIGHT: medium none" id="3075a29bd38c4ad789bff07c4f6c35b1" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 30%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">BALCHEM CORPORATION<a name="_DV_M385"><!--Anchor--></a></div>
</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 20%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
</tr>

<tr>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 30%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 20%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
</tr>

<tr>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
<td style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: medium none; WIDTH: 30%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: left; FONT-VARIANT: normal; FONT-STYLE: normal; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: normal">By:/s/ Matthew D. Houston</div>
</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 20%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
</tr>

<tr>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 30%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none" colspan="2">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Matthew D. Houston, General Counsel and Secretary</div>
</td>
</tr>

<tr>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 30%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>
</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 20%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
</tr>

<tr>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 50%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Dated: December 18, 2015</div>
</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 30%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 20%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
</tr>
</table>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div style="MARGIN-TOP: 10pt; MARGIN-BOTTOM: 10pt; CLEAR: both" id="DSPFPageBreakArea">
<div style="PAGE-BREAK-AFTER: always" id="DSPFPageBreak">
<hr style="BORDER-RIGHT-WIDTH: 0px; BACKGROUND-COLOR: #000000; MARGIN: 4px 0px; WIDTH: 100%; BORDER-TOP-WIDTH: 0px; BORDER-BOTTOM-WIDTH: 0px; HEIGHT: 2px; COLOR: #000000; CLEAR: both; BORDER-LEFT-WIDTH: 0px" noshade="noshade">
</div>
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Exhibit Index</div>

<div><br>
</div>

<table style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; BORDER-TOP: medium none; BORDER-RIGHT: medium none" id="00b912e379f04a35ac1da0969a203322" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 18%; WHITE-SPACE: nowrap; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>Exhibit Number</u></div>
</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 2%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 80%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><u>Description</u></div>
</td>
</tr>

<tr>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 18%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 2%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 80%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
</tr>

<tr>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 18%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><a href="ex99_1.htm">99.1</a></div>
</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 2%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 80%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Press Release of Balchem Corporation, dated December 18, 2015.</div>
</td>
</tr>
</table>

<div><br>
 &#160;</div>

<div>
<hr style="TEXT-ALIGN: center; BACKGROUND-COLOR: #000000; HEIGHT: 2px; COLOR: #000000; MARGIN-LEFT: auto; MARGIN-RIGHT: auto" noshade="noshade">
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: Summit Financial Printing, LLC
    Document created using EDGARfilings PROfile 3.6.2.0
    Copyright 1995 - 2015 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="TEXT-ALIGN: right; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" bgcolor="#ffffff" text="#000000">
<div>
<hr style="TEXT-ALIGN: center; BACKGROUND-COLOR: #000000; HEIGHT: 4px; COLOR: #000000; MARGIN-LEFT: auto; MARGIN-RIGHT: auto" noshade="noshade">
</div>

<div style="TEXT-ALIGN: left">Exhibit 99.1</div>

<div style="TEXT-ALIGN: left">&#160;</div>

<div style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center"><img style="WIDTH: 494px; HEIGHT: 47px" src="image0.jpg"></div>

<div style="TEXT-ALIGN: center">&#160;</div>

<div style="TEXT-ALIGN: left">
<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">FOR IMMEDIATE RELEASE</div>

<div><br>
</div>

<div style="TEXT-ALIGN: center; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balchem Corporation Announces Dividend</div>

<div>&#160;</div>

<div style="TEXT-ALIGN: justify; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">New Hampton, New York. December 18, 2015.</font>&#160; Balchem Corporation (NASDAQ: BCPC) today announced that its Board of Directors has declared a dividend on its shares of common stock equal to $0.34 per share, payable on January 21, 2016 to holders of record on December 28, 2015. This dividend reflects a 13% increase over the prior year cash dividend.</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Ted Harris, Balchem&#8217;s President and CEO, stated, &#8220;Balchem has a long standing commitment to an annual dividend and we are pleased to announce the continuation of that commitment.&#160; This dividend represents the seventh consecutive increase in our annual dividend, reflecting both the consistently outstanding economic performance the company has delivered and the Board&#8217;s continued confidence in our long term strategies.&#160; We are particularly pleased that over this same seven year period, the annual return of cash to our shareholders via a dividend has increased approximately 250% from $3 million to $11 million.&#8221;</div>

<div><br>
</div>

<div style="TEXT-ALIGN: justify; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About Balchem</div>

<div style="TEXT-ALIGN: justify; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">Balchem Corporation consists of four business segments: SensoryEffects; Animal Nutrition and Health; ARC Specialty Products; and Industrial Products. The SensoryEffects segment provides customized food and beverage ingredient systems and proprietary microencapsulation solutions to a variety of applications in the human food, pharmaceutical and nutrition marketplaces.&#160; The Animal Nutrition and Health segment manufactures and supplies products to numerous animal health markets.&#160; Through ARC Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and the Industrial Products segment, provides certain derivative products into industrial applications, predominately as a component for hydraulic fracturing of shale natural gas wells.</div>

<div><br>
</div>

<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Forward-Looking Statements</div>

<div style="TEXT-ALIGN: justify; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">This release contains forward-looking statements, which reflect Balchem&#8217;s expectation or belief concerning future events that involve risks and uncertainties. Balchem can give no assurance that the expectations reflected in forward looking statements will prove correct and various factors could cause results to differ materially from Balchem&#8217;s expectations, including risks and factors identified in Balchem&#8217;s annual report on Form 10-K for the year ended December 31, 2014. Forward-looking statements are qualified in their entirety by the above cautionary statement. Balchem assumes no duty to update its outlook or other forward-looking statements as of any future date.</div>

<div style="TEXT-ALIGN: justify; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">&#160;</div>

<div>
<table style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; BORDER-TOP: medium none; BORDER-RIGHT: medium none" id="b213efd1c2f846c2bc424415c76f2816" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 7%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Contact:</div>
</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 93%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt">William Backus, Chief Financial Officer</div>
</td>
</tr>

<tr>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 7%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">&#160;</td>
<td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; WIDTH: 93%; VERTICAL-ALIGN: top; BORDER-TOP: medium none; BORDER-RIGHT: medium none">
<div style="TEXT-ALIGN: left; FONT-FAMILY: 'Times New Roman', Times, serif; MARGIN-LEFT: 27pt; FONT-SIZE: 10pt">Telephone:&#160; 845-326-5600</div>
</td>
</tr>
</table>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table style="WIDTH: 100%; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-SIZE: 10pt" id="f8b83a6db96e487397673978c441316f" border="0" cellspacing="0" cellpadding="2">
<tr>
<td style="WIDTH: 17%; WHITE-SPACE: nowrap; FONT-SIZE: 8pt">
<div style="TEXT-ALIGN: center">52 Sunrise Park Road</div>
</td>
<td style="TEXT-ALIGN: center; WIDTH: 2%; FONT-SIZE: 8pt">&#8226;</td>
<td style="WIDTH: 24%; WHITE-SPACE: nowrap; FONT-SIZE: 8pt">
<div style="TEXT-ALIGN: center">New Hampton, New York 10958</div>
</td>
<td style="TEXT-ALIGN: center; WIDTH: 2%; FONT-SIZE: 8pt">&#8226;</td>
<td style="WIDTH: 17%; WHITE-SPACE: nowrap; FONT-SIZE: 8pt">
<div style="TEXT-ALIGN: center">Tel. 845.326.5600</div>
</td>
<td style="TEXT-ALIGN: center; WIDTH: 2%; FONT-SIZE: 8pt">&#8226;</td>
<td style="WIDTH: 17%; WHITE-SPACE: nowrap; FONT-SIZE: 8pt">
<div style="TEXT-ALIGN: center">Fax 845.326.5742</div>
</td>
<td style="TEXT-ALIGN: center; WIDTH: 2%; FONT-SIZE: 8pt">&#8226;</td>
<td style="TEXT-ALIGN: center; WIDTH: 17%; WHITE-SPACE: nowrap; MARGIN-LEFT: 18pt; FONT-SIZE: 8pt">www.balchem.com</td>
</tr>
</table>
</div>

<div><br>
</div>

<div>
<hr style="TEXT-ALIGN: center; BACKGROUND-COLOR: #000000; HEIGHT: 2px; COLOR: #000000; MARGIN-LEFT: auto; MARGIN-RIGHT: auto" noshade="noshade">
</div>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !R IT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI66\6$)*8>27W?*.._\ ]:O<6M2*6_+OV/)VA)O;FV[GOE%16PD6UA$QS*$
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MX!U02J"88_.0^C*<_P"(_&D^'7B*VUWPE9*DJFZM8EAGCS\RE1@''H0!6/\
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M_P!_%K7V>)MRZV]2/W5[V_ ] J&\M(+^SFM+E/,@F0I(F<;E/45PO_"T[?\
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MO_T![G_OXM'_  M.W_Z ]S_W\6CZM5[![2)?G^%_A2:X,\=C);.>OV>=T'Y
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M25C4D@$G)Z^]698HYHGBE17C<%65AD$'J#7!?\+3M_\ H#W/_?Q:/^%IV_\
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E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
